Correction to "Discovery and Feasibility Study of Medical Fluorophore 33 as a Novel Theranostic Agent"
ACS Appl Mater Interfaces
.
2024 Apr 3;16(13):17062.
doi: 10.1021/acsami.4c03839.
Epub 2024 Mar 21.
Authors
Kwang Hee Son
1
2
3
,
Da Sol Lee
1
,
Geumi Park
1
,
So Yeon Jeon
1
,
Jae-Eon Lee
1
,
Hui-Jeon Jeon
4
,
Sijoon Lee
1
,
Woo-Jin Park
5
,
Yeonju Shin
6
,
Seong Gon Kim
6
,
Dong-Seok Lee
2
3
,
Ye Ri Han
4
,
Dong-Su Kim
6
,
Yong Hyun Jeon
1
Affiliations
1
Preclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of Korea.
2
School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu 41566, Republic of Korea.
3
School of Life Sciences & Biotechnology, College of Natural Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.
4
New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDIhub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of Korea.
5
Department of Chemistry, Center for NanoMedicine, Institute for Basic Science (IBS), Seoul 03722, Republic of Korea.
6
Therapeutics and Biotechnology Division, Korea Research, Institute of Chemical Technology, 141 Gajeongro, Yuseong, Daejeon 31414, South Korea.
PMID:
38512298
DOI:
10.1021/acsami.4c03839
No abstract available
Publication types
Published Erratum